For more updates, visit Market Realist’s Healthcare page.
How Cannabis Stocks Fared Last Week
Tilray was the top performer in the cannabis sector last week with a rise of 49% as a result of better-than-expected second-quarter earnings and guidance.
Nov. 20 2020, Updated 4:04 p.m. ET
Sector performance
Last week was broadly positive for the cannabis sector. The Horizons Marijuana Life Sciences ETF (HMMJ) rose ~5.4%, while the Alternative Harvest ETF (MJ) rose 3.6%. Last week most of the cannabis stocks ended in the positive territory except for a few such as Cronos Group (CRON). CRON fell due to a Scathing Report on August 30.
Cannabis stocks
Between the close on August 24 and the close on August 31, Tilray (TLRY) emerged as the biggest gainer in the sector. Tilray rose by ~49% as a result of its better-than-expected second-quarter earnings and guidance. Read Digging Deeper into Tilray’s Second-Quarter Earnings for more information. Aphria (APHQF) was next with a weekly gain of 21.2% followed by Supreme Cannabis (SPRWF), which gained 18.8% last week.
Organigram (OGRMF) was also among the top gainers with a rise of 11.1%, followed by CannTrust (CNTTF), which gained 6.6% during the week. Hydropothecary (HEXO) gained 4.7%. Two of the biggest cannabis stocks, Aurora Cannabis (ACB) and Canopy Growth (CGC) (WEED), also ended last week higher by 2.4% and 1.6%, respectively. In contrast, Emerald Health (EMHTF) lost about 3%, and Cronos Group lost about 1.3% last week.
YTD (year-to-date), Canopy Growth remains on the top with a 77% gain, followed by Organigram, which gained 46%, and Cronos Group, which is still up 25.6% despite last week’s decline. Among the worst YTD performers were Aurora Cannabis with a 25.5% decline and Supreme Cannabis with a 25% decline YTD.